Microbix Biosystems Inc.
MBX.TO
TSX
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.32% | 8.32% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 11.32% | 8.32% | |||
| Cost of Revenue | 10.27% | 8.74% | |||
| Gross Profit | 12.85% | 7.73% | |||
| SG&A Expenses | -8.61% | 7.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.88% | 7.77% | |||
| Operating Income | 33.34% | -6.30% | |||
| Income Before Tax | 24.95% | 6.05% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 22.12% | 9.46% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 22.12% | 9.46% | |||
| EBIT | 33.34% | -6.30% | |||
| EBITDA | 43.46% | -17.59% | |||
| EPS Basic | 24.05% | 5.95% | |||
| Normalized Basic EPS | 25.49% | 3.77% | |||
| EPS Diluted | 25.93% | 6.90% | |||
| Normalized Diluted EPS | 25.49% | 3.77% | |||
| Average Basic Shares Outstanding | 2.08% | -3.10% | |||
| Average Diluted Shares Outstanding | 2.08% | -3.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||